肺结核
医学
传染病(医学专业)
疾病
全球卫生
广泛耐药结核
抗药性
环境卫生
结核分枝杆菌
人类免疫缺陷病毒(HIV)
病毒学
免疫学
公共卫生
内科学
病理
微生物学
生物
作者
Tedros Adhanom Ghebreyesus,Nísia Trindade Lima
标识
DOI:10.1016/s1473-3099(23)00589-3
摘要
Tuberculosis is one of the world's oldest and deadliest infectious diseases. Every year, more than 10 million people fall ill with tuberculosis, and more than a million die from the disease, most of whom are adults and adolescents. 1 WHOGlobal tuberculosis report 2022. World Health Organization, Geneva2022 Google Scholar With close to half a million people contracting drug-resistant forms of tuberculosis annually, antimicrobial resistance risks making the disease even more deadly and incurable. A new agenda to control tuberculosisTuberculosis remains one of the deadliest infectious diseases in the world, particularly in low-income and middle-income countries. An estimated global total of 10·6 million people fell ill with the disease and 1·6 million succumbed to it in 2021. The rise of multidrug-resistant and extensively drug-resistant tuberculosis, together with slow development of new drugs and vaccines, co-infection with HIV, a partially effective vaccine, and stagnant funding, continue to impede the fight against this disease. Full-Text PDF
科研通智能强力驱动
Strongly Powered by AbleSci AI